Mohammed VI Fund Takes 10% in Marbio
The Mohamed VI Investment Fund has announced its acquisition of a 10% stake in Marbio, a company specializing in the manufacturing of vaccines and biopharmaceutical products in Morocco. This move follows the completion of the company's initial development phase and the support it received from its partners, particularly Resifarm. The initiative is part of a broader plan to enhance the country's health sovereignty and to establish industrial and technological capabilities in vaccine production. Additionally, the company's activities will be expanded to encompass the African region. The fund is now directly involved as a major shareholder to support the company's growth and ensure national industrial and technological sustainability. Since its inception in 2021, the project has been valued at a capital of 1.4 billion dirhams. Its goal is to strengthen Morocco's vaccine manufacturing capacity and secure long-term health supply security.
Notice: This Is an AI-Generated Summary
Comments (0)